![]() |
3rd International AIDS Society Conference on HIV Pathogenesis and TreatmentRio de Janeiro - July 24 - 27, 2005 |
PATTERN OF HEPATOTOXICITY ON DIFFERENT ANTIRETROVIRAL REGIMENS IN HIV-PATIENTS WITH OR WITHOUT CHRONIC HEPATITIS
IAS Conf HIV Pathog Treat 2005 Jul 24-27;3rd: Abstract No. TuPe2.1B03
Konopnicki D., De Wit S., Poll B., Clumeck N.
Saint-Pierre University Hospital, Brussels, Belgium
INTRODUCTION: To determine the incidence of liver enzymes increase (LEI) after initiation of antiretroviral therapy and to correlate it with sex, ethnicity, CD4 level and chronic hepatitis.
METHODS: Cohort of patients naïve for PI and NNRTI starting between 1996 and 2004 a NNRTI- (n=488), a PI- (n=770) or a triple NRTI- (n=293) based-regimen. Alanine-(ALT) and aspartate-(AST) aminotransferase, alkalin phosphatase (AP) and gamma-glutamyl transpeptidase (GGT) were collected at baseline and during the first year. Patients were classified as hepatitis B (5%) or C (13%) co-infected (H) or not (NH).
RESULTS: The NNRTI, PI and NRTI groups were characterised by a high proportion of female (51-46-46%), Africans (61-51-44%) and chronic hepatitis (15-18-18%). Table 1 shows the proportion of patients with >2 grades LEI. An increase of >2 grades of at least 1 enzyme was more frequent in H vs. NH patients with PI (24% vs. 12%, p=0.0004) or NRTI (14% vs. 4%, p=0.02). For the PI group, the multivariate analysis (including sex, ethnicity, hepatitis status, baseline CD4 >250 cells/µL) showed that chronic hepatitis increased the risk of >2 grades LEI (OR 1.87, 1.12-3.13, p=0.02) while female sex (OR 0.42, 0.24-0.73 , p=0.002) or CD4 >250/µL (OR 0.47, 0.28-0.78, p=0.004) decreased that risk.
CONCLUSIONS: Serious hepatotoxicity occurred in 20% of NNRTI-, 14% of PI- and 6% of NRTI-based therapies. GGT was more frequently increased that ALT/AST whereas increased AP was a rare event. PI and NRTI but not NNRTI increased hepatic abnormalities in chronic hepatitis patients. Female were less at risk for hepatotoxicity on PI and in contrast with previous studies, had no increased risk with NNRTI.
Download PDF of this abstract.
050724
Basic | TuPe2.1B03 | Deborah Konopnicki
Metaanalysis of adverse events in different settings
Copyright © 2005 - International AIDS Society (IAS). All information and content relating to the abstracts from the 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment, such as text, graphics, logos, button icons, images, audio clips, and software is protected by copyright. Permission is hereby granted for the non-commercial use or reproduction of the information on this web site, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.
AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Permission is hereby granted for the non-commercial use or reproduction of the information herein, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.